Study of anti-Müllerian hormone and its relation to the subsequent probability of pregnancy in 112 patients with systemic lupus erythematosus, exposed or not to cyclophosphamide.

MLA

Morel, Nathalie, et al. “Study of Anti-Müllerian Hormone and Its Relation to the Subsequent Probability of Pregnancy in 112 Patients with Systemic Lupus Erythematosus, Exposed or Not to Cyclophosphamide.” The Journal of Clinical Endocrinology and Metabolism, vol. 98, no. 9, Sept. 2013, pp. 3785–92. EBSCOhost, https://doi.org/10.1210/jc.2013-1235.

APA

Morel, N., Bachelot, A., Chakhtoura, Z., Ghillani-Dalbin, P., Amoura, Z., Galicier, L., Aumaitre, O., Piette, J.-C., Pourrat, J., Boutin, D., Sacre, K., Kahn, J.-E., Duhaut, P., Farge, D., Francès, C., Guettrot-Imbert, G., Harlé, J.-R., Lambotte, O., Le Guern, V., … Costedoat-Chalumeau, N. (2013). Study of anti-Müllerian hormone and its relation to the subsequent probability of pregnancy in 112 patients with systemic lupus erythematosus, exposed or not to cyclophosphamide. The Journal of Clinical Endocrinology and Metabolism, 98(9), 3785–3792. https://doi.org/10.1210/jc.2013-1235

Chicago

Morel, Nathalie, Anne Bachelot, Zeina Chakhtoura, Pascale Ghillani-Dalbin, Zahir Amoura, Lionel Galicier, Olivier Aumaitre, et al. 2013. “Study of Anti-Müllerian Hormone and Its Relation to the Subsequent Probability of Pregnancy in 112 Patients with Systemic Lupus Erythematosus, Exposed or Not to Cyclophosphamide.” The Journal of Clinical Endocrinology and Metabolism 98 (9): 3785–92. doi:10.1210/jc.2013-1235.